Burning Rock Biotech (BNR) Receivables - Other (2019 - 2025)

Burning Rock Biotech's Receivables - Other history runs 7 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• In Q4 2025, Receivables - Other fell 10.08% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 10.08% YoY), while the FY2025 annual figure was $1.8 million, down 7.32% from the prior year.
• Receivables - Other was $1.7 million for Q4 2025 at Burning Rock Biotech, down from $1.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $32.1 million in Q2 2022 to a low of $79000.0 in Q1 2021.
• Historically, Receivables - Other has averaged $5.2 million across 5 years, with a median of $3.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other soared 32972.16% in 2022, then plunged 74.72% in 2023.
• A 5-year view of Receivables - Other shows it stood at $6.6 million in 2021, then dropped by 11.45% to $5.9 million in 2022, then sank by 46.19% to $3.2 million in 2023, then sank by 38.95% to $1.9 million in 2024, then decreased by 10.08% to $1.7 million in 2025.
• The last three Receivables - Other figures came in at $1.7 million (Q4 2025), $1.8 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.